GeneDx Holdings Corp. Files Form 144 for Security Sale
Ticker: WGS · Form: 144 · Filed: Apr 29, 2026 · CIK: 0001818331
| Field | Detail |
|---|---|
| Company | Genedx Holdings Corp. (WGS) |
| Form Type | 144 |
| Filed Date | Apr 29, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, proposed-sale, sec-filing
Related Tickers: WGS
TL;DR
GeneDx Holdings Corp. filing 144 - looks like a sale is coming.
AI Summary
On April 29, 2026, GeneDx Holdings Corp. filed a Form 144, indicating a proposed sale of securities. The filing was made by Katherine Stueland, who is listed as the reporting person. The company's principal executive offices are located in Stamford, CT.
Why It Matters
This filing signals potential selling pressure on GeneDx Holdings Corp. stock, which could impact its market price.
Risk Assessment
Risk Level: medium — Form 144 filings indicate potential stock sales, which can create downward price pressure.
Key Numbers
- 2026-04-29 — Filing Date (Date the Form 144 was filed)
Key Players & Entities
- GeneDx Holdings Corp. (company) — Subject of the filing
- Katherine Stueland (person) — Reporting person
- 0001818331 (company) — CIK for GeneDx Holdings Corp.
- 0001689575 (company) — CIK for reporting person
FAQ
What is the purpose of a Form 144 filing?
A Form 144 filing is a notice of proposed sale of restricted securities or control securities.
Who is Katherine Stueland in relation to GeneDx Holdings Corp.?
Katherine Stueland is listed as the reporting person for this Form 144 filing.
What is the business address of GeneDx Holdings Corp.?
The business address for GeneDx Holdings Corp. is 333 LUDLOW STREET NORTH TOWER, 6TH FLOOR STAMFORD CT 06902.
What is the CIK number for GeneDx Holdings Corp.?
The CIK number for GeneDx Holdings Corp. is 0001818331.
When was this Form 144 filing accepted by the SEC?
This Form 144 filing was accepted by the SEC on 2026-04-29 at 18:53:14.
Filing Details
This Form 144 (Form 144) was filed with the SEC on April 29, 2026 by Katherine Stueland regarding GeneDx Holdings Corp. (WGS).